European vs. Egyptian HCV-4 Patients with Elevated Baseline HCV RNA, Treated with PEG-IFN-α2a and Ribavirin: The Role of Rapid and Early Virologic Response

AUTHORS

Dimitrios Dimitroulopoulos 1 , * , Ioannis Elefsiniotis 2 , Christos Pavlidis 3 , Dimitrios Xinopoulos 1 , Klisthenis Tsamakidis 1 , Stamatina Patsavela 1 , Dimitrios Kypreos 1 , Ageliki Ferderigou 4 , Dimitrios Korkolis 5 , Sotirios Koutsounas 6 , Georgios Saroglou 7 , Emmanouil Paraskevas 8

1 Department of Gastroenterology, Agios Savvas Hospital, Athens, Greece

2 Department of Internal Medicine, Helena Venizelou Hospital–University of Athens, Athens, Greece

3 Reference Center for Viral Hepatitis,IKA, Athens, Athens, Greece

4 Department of Biochemistry, Agios Savvas Hospital, Athens, Greece

5 First Surgical Department, Agios Savvas Hospital, Athens, Greece

6 Reference Center for Viral Hepatitis, IKA, Athens, Greece

7 Department of Internal Medicine, Helena Venizelou Hospital – University of Athens, Athens, Greece

8 Department of Gastroenterology,Agios SavvasHospital, Athens, Greece

How to Cite: Dimitroulopoulos D, Elefsiniotis I, Pavlidis C, Xinopoulos D, Tsamakidis K, et al. European vs. Egyptian HCV-4 Patients with Elevated Baseline HCV RNA, Treated with PEG-IFN-α2a and Ribavirin: The Role of Rapid and Early Virologic Response, Hepat Mon. 2010 ; 10(3):e92981.

ARTICLE INFORMATION

Hepatitis Monthly: 10 (3); e92981
Published Online: June 30, 2010
Article Type: Research Article
Received: May 05, 2019
Accepted: June 30, 2010

Crossmark

CHEKING

READ FULL TEXT
Abstract

Keywords

HCV Genotype 4 EVR RVR Treatment

© 2010, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Fulltext

References

  • 1.

    The references are available in the PDF file.

  • COMMENTS

    LEAVE A COMMENT HERE: